Oxidative phosphorylation defect in the brains of carriers of the tRNA(leu(UUR)) A3243G mutation in a MELAS pedigree

Annals of Neurology

Volumn 47, Issue 2, 2000, Pages 179-185

  Dubeau, François ^a   De Stefano, Nicola ^c   Zifkin, Benjamin G ^b   Arnold, Douglas L ^a   Shoubridge, Eric A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Laboratorio di Neuropatogia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MALE; MELAS SYNDROME; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; RNA ANALYSIS;

ADULT; AGED; BRAIN; DNA, MITOCHONDRIAL; FEMALE; HETEROZYGOTE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MELAS SYNDROME; MIDDLE AGED; MUTATION; OXIDATIVE PHOSPHORYLATION; PEDIGREE; PHENOTYPE; RNA, TRANSFER, LEU;

EID: 0033950567     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z     Document Type: Article

References (29)

1. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488
2. Goto Y, Nonaka I, Horai S. A mutation in the tRNA (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653 (Comments)
3. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 1993; 3:43-50
4. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-968
5. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992;340:1376-1379 (Comments)
6. van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-371
7. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31: 391-398
8. Martinuzzi A, Bartolomei L, Carrozzo R, et al. Correlation between clinical and molecular features in two MELAS families. J Neurol Sci 1992;113:222-229
9. Mariotti C, Savarese N, Suomalainen A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995;242:304-312
10. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 1992;89:4221-4225
11. King MP, Koga Y, Davidson M, Schon EA. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol 1992;12:480-490
12. Dunbar DR, Moonie PA, Zeviani M, Holt IJ. Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. Hum Mol Genet 1996;5:123-129
13. Miyabayashi S, Hanamizu H, Nakamura R, et al. Defects of mitochondrial respiratory enzymes in cloned cells from MELAS fibroblasts. J Inherit Metab Dis 1992;15:797-802
14. Boulet L, Karpati G, Shoubridge EA. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992;51:1187-1200
15. Fu K, Hartlen R, Johns T, et al. A novel heteroplasmic tRNA Leu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 1996;5:1835-1840
16. Macmillan C, Lach B, Shoubridge EA. Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 1993;43:1586-1590
17. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998;121:1889-1894
18. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-727
19. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30: 341-344
20. de Beer R, van den Boogaart A, van Ormondt D, et al. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 1992;5: 171-178
21. Ozawa M, Nonaka I, Goto Y. Single muscle fiber analysis in patients with 3243 mutation in mitochondrial DNA: comparison with the phenotype and the proportion of mutant genome. J Neurol Sci 1998;159:170-175
22. Petruzzella V, Moraes CT, Sano MC, et al. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994;3:449-454
23. Poulton J, Morten K. Noninvasive diagnosis of the MELAS syndrome from blood DNA. Ann Neurol 1993;34:116 (Letter)
24. Sue CM, Quigley A, Katsabanis S, et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 1998;161:36-39
25. Jenuth JP, Peterson AC, Fu K, Shoubridge EA. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet 1996;14:146-151
26. Cendes F, Stanley JA, Dubeau F, et al. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol 1997;41:74-81
27. De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909
28. Arnold DL, Matthews PM. Practical aspects of clinical applications of MRS in the brain. In: Young IR, Charles HC, eds. MR spectroscopy: clinical applications and techniques. London: Martin Dunitz, 1996:139-159
29. Ciafaloni E, Ricci E, Servidei S, et al. Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 1991;41: 1663-1664